loadpatents
name:-0.094092130661011
name:-0.052345037460327
name:-0.046483993530273
Ngamcherdtrakul; Worapol Patent Filings

Ngamcherdtrakul; Worapol

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ngamcherdtrakul; Worapol.The latest application filed is for "therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor".

Company Profile
4.4.10
  • Ngamcherdtrakul; Worapol - Portland OR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Therapeutic Constructs For Co-delivery Of Mitotic Kinase Inhibitor And Immune Checkpoint Inhibitor
App 20220257516 - Yantasee; Wassana ;   et al.
2022-08-18
Immunotherapeutic Constructs And Methods Of Their Use
App 20220249389 - Yantasee; Wassana ;   et al.
2022-08-11
Cross-linked Polymer Modified Nanoparticles
App 20220211878 - Yantasee; Wassana ;   et al.
2022-07-07
Cross-linked polymer modified nanoparticles
Grant 11,305,024 - Yantasee , et al. April 19, 2
2022-04-19
Immunogenic Constructs, Compositions, And Methods For Inducing Immune Response
App 20220111039 - Yantasee; Wassana ;   et al.
2022-04-14
Immunotherapeutic Constructs And Methods Of Their Use
App 20220096628 - Yantasee; Wassana ;   et al.
2022-03-31
Therapeutic Constructs For Co-delivery Of Mitotic Kinase Inhibitor And Immune Checkpoint Inhibitor
App 20220071906 - Yantasee; Wassana ;   et al.
2022-03-10
Immunotherapeutic constructs and methods of their use
Grant 11,235,058 - Yantasee , et al. February 1, 2
2022-02-01
Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor
Grant 11,224,573 - Yantasee , et al. January 18, 2
2022-01-18
Cross-linked polymer modified nanoparticles
Grant 11,207,428 - Yantasee , et al. December 28, 2
2021-12-28
Cross-linked Polymer Modified Nanoparticles
App 20210393806 - Yantasee; Wassana ;   et al.
2021-12-23
Therapeutic Constructs For Co-delivery Of Mitotic Kinase Inhibitor And Immune Checkpoint Inhibitor
App 20210030679 - Yantasee; Wassana ;   et al.
2021-02-04
Immunotherapeutic Constructs And Methods Of Their Use
App 20210008198 - YANTASEE; Wassana ;   et al.
2021-01-14
Cross-linked Polymer Modified Nanoparticles
App 20170173169 - YANTASEE; Wassana ;   et al.
2017-06-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed